AAIC 2025 Abstract
Imaging‐neuropathology evaluation of Amyloid Related Imaging Abnormality sulcal effusion in a DIAN‐TU‐001 participant treated with gantenerumab
By Nelly Joseph-Mathurin, Charles D. Chen, Diana A. Hobbs, Show 23 more authorsTammie L.S. Benzinger
Trial in peopleInterventions
Abstract
Background: Amyloid related imaging abnormality edema (ARIA‐E) occurs in about 19% of individuals with autosomal dominant Alzheimer disease (ADAD) treated with an anti‐amyloid‐b monoclonal antibody (Salloway et al., 2021).
